Citigroup’s Xeris Biopharma Holdings XERS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$362K Sell
77,534
-40,674
-34% -$190K ﹤0.01% 3094
2025
Q1
$649K Sell
118,208
-14,238
-11% -$78.2K ﹤0.01% 2805
2024
Q4
$449K Buy
132,446
+13,019
+11% +$44.1K ﹤0.01% 3097
2024
Q3
$340K Buy
119,427
+74,082
+163% +$211K ﹤0.01% 3237
2024
Q2
$102K Buy
45,345
+3,583
+9% +$8.06K ﹤0.01% 3478
2024
Q1
$92.3K Buy
41,762
+19,818
+90% +$43.8K ﹤0.01% 3593
2023
Q4
$51.6K Buy
21,944
+20,147
+1,121% +$47.3K ﹤0.01% 3754
2023
Q3
$3.34K Sell
1,797
-40,172
-96% -$74.7K ﹤0.01% 4087
2023
Q2
$110K Buy
41,969
+40,420
+2,609% +$106K ﹤0.01% 3533
2023
Q1
$2.53K Sell
1,549
-1,006
-39% -$1.64K ﹤0.01% 4350
2022
Q4
$3.4K Sell
2,555
-997
-28% -$1.33K ﹤0.01% 4363
2022
Q3
$6K Sell
3,552
-5,809
-62% -$9.81K ﹤0.01% 4411
2022
Q2
$14K Sell
9,361
-325,789
-97% -$487K ﹤0.01% 4488
2022
Q1
$858K Buy
335,150
+331,429
+8,907% +$848K ﹤0.01% 2478
2021
Q4
$11K Sell
3,721
-2,023
-35% -$5.98K ﹤0.01% 4771
2021
Q3
$14K Sell
5,744
-1,590
-22% -$3.88K ﹤0.01% 4627
2021
Q2
$30K Sell
7,334
-453
-6% -$1.85K ﹤0.01% 4416
2021
Q1
$35K Sell
7,787
-6,234
-44% -$28K ﹤0.01% 4255
2020
Q4
$69K Buy
14,021
+3,939
+39% +$19.4K ﹤0.01% 3912
2020
Q3
$60K Sell
10,082
-1,034
-9% -$6.15K ﹤0.01% 3393
2020
Q2
$29K Buy
11,116
+1,644
+17% +$4.29K ﹤0.01% 4024
2020
Q1
$18K Sell
9,472
-2,192,367
-100% -$4.17M ﹤0.01% 4417
2019
Q4
$15.5M Buy
2,201,839
+2,198,541
+66,663% +$15.5M 0.01% 640
2019
Q3
$33K Sell
3,298
-5,762
-64% -$57.7K ﹤0.01% 3988
2019
Q2
$103K Buy
9,060
+3,201
+55% +$36.4K ﹤0.01% 3619
2019
Q1
$59K Buy
5,859
+4,395
+300% +$44.3K ﹤0.01% 3914
2018
Q4
$25K Sell
1,464
-386
-21% -$6.59K ﹤0.01% 4324
2018
Q3
$33K Buy
+1,850
New +$33K ﹤0.01% 4319